Home>News & Events>Presentations>HD-RSC

News & Events

  • April 30, 2019

    Huntington’s Disease Regulatory Science Consortium (HD-RSC) Inaugural Meeting Summary

     Introduction Huntington’s Disease Regulatory Science Consortium (HD-RSC) Inaugural Meeting Summary April 29 & 30, 2019 – Rockville, Maryland   The Huntington’s Disease Regulatory Science Consortium (HD-RSC), created in partnership with the CHDI Foundation and the Critical Path Institute (C-Path), was formally launched on March 28, 2018 with the primary goal of defining the regulatory science needs in order......
  • November 6, 2017 - November 7, 2017

    Proceedings from Huntington’s Disease Regulatory Science Consortium (HD-RSC) Kick-Off Meeting, Nov. 6-7, 2017

     On November 6 and 7, 2017, in Silver Spring, MD, Critical Path Institute and CHDI Foundation welcomed participants from the pharmaceutical industry, academia, regulatory agencies, and advocacy groups to a kick-off meeting for the Huntington’s Disease Regulatory Science Consortium (HD-RSC). The meeting objectives were to solicit input from stakeholders on HD-RSC plans and deliverables, and......
Refine:

Period

Program

  • All Programs
  • CPAD - Critical Path For Alzheimer's Disease
  • TTC - Transplant Therapeutics Consortium
  • T1D - Type 1 Diabetes Consortium
  • HD-RSC - Huntington’s Disease Regulatory Science Consortium
  • RDCA-DAP - Rare Disease Cures Accelerator-Data and Analytics Platform
  • TOMI-T1D - Trial Outcome Markers Initiative in T1D
  • QuantMed - Quantitative Medicine Program
  • PredicTox KE - PredicTox Knowledge Environment
  • CDRC - CURE Drug Repurposing Collaboratory
  • SHIP-MD - System of Hospitals for Innovation in Pediatrics – Medical Devices
  • CPTA - Critical Path to Therapeutics for the Ataxias
  • CP-SCD - Critical Path for Sickle Cell Disease
  • RD-COA Consortium - Rare Disease Clinical Outcome Assessment Consortium
  • TRxA - Translational Therapeutics Accelerator
  • CP-RND - Critical Path for Rare Neurodegenerative Diseases
  • CPA-1 - Critical Path for Alpha-1 Antitrypsin Deficiency
  • CFAST - Coalition For Accelerating Standards and Therapies
  • BmDR - Biomarker Data Repository
  • CPP - Critical Path for Parkinson's
  • CPTR - Critical Path to TB Drug Regimens
  • DCC - Data Collaboration Center
  • D-RSC - Duchenne Regulatory Science Consortium
  • INC - International Neonatal Consortium
  • MSOAC - Multiple Sclerosis Outcome Assessments Consortium
  • PKD - Polycystic Kidney Disease Outcomes Consortium
  • PRO Consortium - Patient-Reported Outcome Consortium
  • eCOA Consortium - Electronic Clinical Outcome Assessment Consortium
  • PSTC - Predictive Safety Testing Consortium
  • PTC - Pediatric Trials Consortium
  • TB-PACTS - TB-Platform for Aggregation of Clinical TB Studies

Category

Tags

x